Pfizer announced on Tuesday that its experimental oral pill for COVID-19, PAXLOVID, worked against the Omicron variant in laboratory studies. Pfizer had announced in November that the pill helps to
Pfizer announced on Tuesday that its experimental oral pill for COVID-19, PAXLOVID, worked against the Omicron variant in laboratory studies. Pfizer had announced in November that the pill helps to